Financial Fitness Check: Examining Incyte Corp (INCY)’s Key Ratios

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

In the latest session, Incyte Corp (NASDAQ: INCY) closed at $86.92 up 0.88% from its previous closing price of $86.16. In other words, the price has increased by $0.88 from its previous closing price. On the day, 1.88 million shares were traded. INCY stock price reached its highest trading level at $87.06 during the session, while it also had its lowest trading level at $85.42.

Ratios:

For a deeper understanding of Incyte Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.01 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.72. For the most recent quarter (mrq), Quick Ratio is recorded 2.78 and its Current Ratio is at 2.85. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

On August 01, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $90.

Stifel Upgraded its Hold to Buy on June 16, 2025, while the target price for the stock was maintained at $107.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 15 ’25 when SHEILA DENTON bought 277 shares for $86.81 per share.

BARRY FLANNELLY bought 75,963 shares of INCY for $6,267,540 on Aug 13 ’25. On Aug 12 ’25, another insider, BARRY FLANNELLY, who serves as the Officer of the company, bought 14,037 shares for $80.00 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INCY now has a Market Capitalization of 16973389824 and an Enterprise Value of 14594072576. As of this moment, Incyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.76, and their Forward P/E ratio for the next fiscal year is 12.24. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.70 while its Price-to-Book (P/B) ratio in mrq is 4.05. Its current Enterprise Value per Revenue stands at 3.183 whereas that against EBITDA is 13.756.

Stock Price History:

The Beta on a monthly basis for INCY is 0.75, which has changed by 0.374012 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, INCY has reached a high of $86.50, while it has fallen to a 52-week low of $53.56. The 50-Day Moving Average of the stock is 20.90%, while the 200-Day Moving Average is calculated to be 25.59%.

Shares Statistics:

For the past three months, INCY has traded an average of 1.86M shares per day and 1869310 over the past ten days. A total of 194.12M shares are outstanding, with a floating share count of 192.55M. Insiders hold about 1.39% of the company’s shares, while institutions hold 102.38% stake in the company. Shares short for INCY as of 1753920000 were 7423372 with a Short Ratio of 3.98, compared to 1751241600 on 7288830. Therefore, it implies a Short% of Shares Outstanding of 7423372 and a Short% of Float of 5.37.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.